Godown Justin, Thurm Cary, Hall Matt, Dodd Debra A, Feingold Brian, Soslow Jonathan H, Mettler Bret A, Smith Andrew H, Bearl David W, Schumacher Kurt R
Pediatric Cardiology, Monroe Carell Jr. Children's Hospital, Nashville, TN, USA.
Children's Hospital Association, Lenexa, KS, USA.
Pediatr Cardiol. 2019 Feb;40(2):357-365. doi: 10.1007/s00246-018-2011-8. Epub 2018 Oct 20.
There are limited published data addressing the costs associated with pediatric heart transplantation and no studies evaluating the variation in costs across centers. We aimed to describe center variation in pediatric heart transplant costs and assess the association of transplant hospitalization costs with patient outcomes. Using a linkage between the Pediatric Health Information System and Scientific Registry of Transplant Recipients databases, hospital costs were assessed for patients (< 18 years of age) undergoing heart transplantation (2007-2016). Severity-adjusted patient costs were calculated using generalized linear mixed-effects models with a random hospital intercept. Center variation in hospital cost was described after adjusting for the predicted risk of in-hospital mortality. Post-transplant survival was compared between low- and high-cost centers using Cox proportional hazard models. A total of 2156 patients were included from 24 centers. There was 3.7-fold variation in transplant hospitalization costs across centers, ranging from $329,477 to $1,226,507. Patients transplanted at high-cost centers have a higher predicted risk of in-hospital mortality (8.1% vs. 6.1%, p < 0.001). Both early (p = 0.008) and long-term (p = 0.003) post-transplant survival were better in patients transplanted at low-cost centers. Transplant at low-cost centers was associated with improved post-transplant survival, independent of patient-specific risk (adjusted hazard ratio 0.72; 95%CI 0.57-0.92, p = 0.008). There is wide variation in cost for pediatric heart transplant inpatient care among U.S. centers with low-cost centers demonstrating the best patient survival. Differences in patient populations likely contribute to these findings, but cannot account for all the variation seen. This suggests that variability in the delivery of care across centers may influence post-transplant survival.
关于小儿心脏移植相关费用的已发表数据有限,且尚无研究评估各中心费用的差异。我们旨在描述小儿心脏移植费用的中心差异,并评估移植住院费用与患者预后之间的关联。通过儿科健康信息系统与移植受者科学注册数据库之间的链接,对接受心脏移植的18岁以下患者(2007 - 2016年)的医院费用进行了评估。使用具有随机医院截距的广义线性混合效应模型计算经严重程度调整后的患者费用。在调整了院内死亡的预测风险后,描述了医院费用的中心差异。使用Cox比例风险模型比较了低成本中心和高成本中心移植后的生存率。共有来自24个中心的2156例患者纳入研究。各中心移植住院费用相差3.7倍,从329,477美元到1,226,507美元不等。在高成本中心接受移植的患者院内死亡预测风险更高(8.1%对6.1%,p < 0.001)。在低成本中心接受移植的患者,移植后的早期(p = 0.008)和长期(p = 0.003)生存率均更好。在低成本中心进行移植与移植后生存率提高相关,与患者个体风险无关(调整后的风险比为0.72;95%CI为0.57 - 0.92,p = 0.008)。美国各中心小儿心脏移植住院护理费用差异很大,低成本中心患者生存率最佳。患者群体的差异可能导致了这些结果,但不能解释所有观察到的差异。这表明各中心护理提供的差异可能会影响移植后的生存率。